IBM, US4592001014

IBM stock falls after EPS miss as $1 billion quantum deal reshapes outlook

Published on 09/19/2026 at 12:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IBM stock has dropped 19.7% year to date after Q2 2026 operating EPS of USD 2.93 missed the USD 2.97 consensus, as reported on September 18, 2026. At the same time, an IBM-backed unit sealed a USD 1 billion CHIPS Act award on September 16, 2026, adding a new quantum manufacturing pillar.

Photorealistic view down a long enterprise mainframe data center corridor, tall black server cabinets lined with glowing blue LED strips on both sides, cool blue ambient light reflecting off the polished floor, deep perspective showing the aisle vanishing — IBM zeigt ein großes Mainframe Rechenzentrum mit intensiver blauer Beleuchtung und Serverreihen US4592001014, Illustration mit AI erstellt.

International Business Machines Corporation (ISIN US4592001014) stock has come under pressure in 2026, with the shares down 19.7 percent year to date after a rare earnings miss in the second quarter and a sharp pullback in its mainframe business, even as the company secured a USD 1 billion quantum manufacturing award on September 16, 2026.

Q2 2026 results show modest growth but EPS miss

As Yahoo Finance reported on September 18, 2026, IBM's revenue in the second quarter of 2026 grew 1.1 percent year over year, while operating EPS came in at USD 2.93, missing the consensus estimate of USD 2.97 by USD 0.04.

Within the quarter, IBM's Software segment delivered 5.1 percent revenue growth, with its Red Hat unit up 11 percent, highlighting continued momentum in hybrid cloud and open source platforms, according to Yahoo Finance.

By contrast, IBM's Infrastructure segment revenue declined 7.4 percent year over year in Q2 2026 as IBM Z mainframe revenue fell 42 percent in what management described as a late-cycle trough, again per Yahoo Finance.

Software strength did translate into better profitability: according to an analysis cited by The Globe and Mail on September 18, 2026, Software segment profit rose 9 percent in Q2 2026 to USD 2.5 billion, with segment margin expanding by 110 basis points to 32.2 percent.

Quantum CHIPS Act award adds long-term pillar

On the strategic side, IBM is deepening its role in quantum hardware supply chains. On September 16, 2026, Anderon LLC, an IBM company, finalized an award of up to USD 1 billion under the U.S. CHIPS and Science Act with the Department of Commerce to build a pure-play quantum wafer foundry in Albany, New York, as summarized by Ground News.

The CHIPS Act award is complemented by an additional USD 1 billion investment commitment from IBM itself, effectively creating a USD 2 billion funding framework for the Albany 300 millimeter quantum wafer facility, according to coverage referenced by Ground News.

The foundry is designed to produce specialized wafers for high-performance superconducting qubit arrays and quantum input output signaling, with plans to support additional quantum modalities over time, per Ground News.

For investors, the combination of a Q2 2026 earnings stumble and a large, long-term quantum manufacturing commitment illustrates IBM's transition: near-term profit pressure from hardware cycles versus a push to anchor future quantum computing ecosystems.

Analyst context and stock performance

The mixed fundamental picture has weighed on IBM stock in 2026. The comparison of AI infrastructure plays by Yahoo Finance notes that IBM shares are down 19.7 percent year to date, while management has cut full-year constant-currency revenue growth guidance to a 4 to 5 percent range, relying on deferred Q2 deals to close later in the year.

An additional press analysis highlighted that IBM shares have lost 10.3 percent over the past 12 months compared with an industry group that gained 171.2 percent, underscoring the stock's underperformance in an AI-driven market, according to The Globe and Mail.

Despite the Q2 shock, some coverage points to a broadly constructive analyst stance, with one widely cited overview mentioning a consensus rating of Moderate Buy and forward price to earnings multiples in the high teens for IBM stock, compared with a sector median near the high twenties, as relayed by a recent feature on MSN that discussed the comeback case.

Earnings estimates have been adjusted but not dramatically cut: the same analysis from The Globe and Mail notes that earnings estimates for 2026 have increased 0.7 percent to USD 12.33 over the past 60 days, while estimates for 2027 have slipped 0.6 percent to USD 13.22, suggesting modest confidence in IBM's ability to stabilize growth.

Short-term pressure from AI market volatility

In the very short term, broader volatility in U.S. AI and technology stocks has added pressure. On September 19, 2026, a flash note from KuCoin News reported that AI-related stocks generally declined, with IBM down 3.45 percent alongside drops in other names such as Symbotic, Accenture, Dell and CrowdStrike.

A separate market wrap from Odaily News on September 19, 2026, similarly noted that IBM fell 3.45 percent on the session, in a context where the Dow Jones Industrial Average slipped 0.18 percent while the Nasdaq Composite rose 0.39 percent.

Technical commentary has turned cautious as well. A same-week analysis from Traders Union described IBM's latest share decline of 2.82 percent in a prior session, pointing out that the stock was trading below its 20 day, 50 day and 200 day moving averages, with immediate resistance identified at USD 233.51 and support at USD 222.87.

IBM stock price and valuation snapshot

According to a same-day price overview from MarketWatch data cited by Yahoo Finance, IBM recently traded at about USD 237.75 on the New York Stock Exchange, implying a forward price to earnings multiple near 18 and a dividend yield around 2.8 percent.

A separate stock portal alert on September 19, 2026, noted that IBM shares opened at USD 230.09 on the New York Stock Exchange and were part of a move where institutional investor Nykredit A S disclosed a holding of 261,487 IBM shares, according to MarketBeat.

In that same context, IBM's recent share slide was described as part of its worst trading day since 1987, as clients shifted spending toward AI hardware vendors, according to a feature highlighted by Startup Fortune on September 19, 2026, which framed the subsequent valuation as potentially attractive relative to peers.

For retail investors, the numbers tell a clear story: in Q2 2026, IBM grew total revenue 1.1 percent, missed EPS consensus by USD 0.04 and saw a 42 percent drop in mainframe revenue, while simultaneously expanding software margins and winning a USD 1 billion federal quantum award backed by another USD 1 billion from its own balance sheet. The market response so far has been a roughly 19.7 percent year to date share price decline and cautious technical signals, but with earnings estimates for 2026 inching higher to USD 12.33 and consensus still leaning positive, IBM stock sits at the intersection of cyclical pressure and long-term quantum ambitions.